Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections.
BACKGROUND: Schistosomiasis has a considerable impact on public health in many tropical and subtropical areas. In the new world, schistosomiasis is caused by the digenetic trematode Schistosoma mansoni. Chemotherapy is the main measure for controlling schistosomiasis, and the current drug of choice...
Main Authors: | Regina Coeli, Elio H Baba, Neusa Araujo, Paulo M Z Coelho, Guilherme Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC3868512?pdf=render |
Similar Items
-
Lethal effect of oxamniquine and praziquantel on mice experimentally infected with Schistosoma mansoni Efeito letal de oxamniquina e praziquantel em camundongos experimentalmente infectados com Schistosoma mansoni
by: Sonia Maria A.F. Tonelli, et al.
Published: (1995-08-01) -
Activity of praziquantel on in vitro transformed Schistosoma mansoni sporocysts
by: ACA Mattos, et al.
Published: (2006-10-01) -
Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails
by: Flávia FB Couto, et al.
Published: (2011-03-01) -
Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni
by: Neusa Araujo, et al.
Published: (2008-12-01) -
THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL
by: Adriana Maria B. MENDONÇA, et al.
Published: (2016-01-01)